Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,984 | 361 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,247 | 127 | $0 (2024) |
| ABBVIE INC. | $1,030 | 50 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $454.24 | 33 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $284.29 | 25 | $0 (2022) |
| Almatica Pharma LLC | $268.22 | 18 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $180.40 | 10 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $177.72 | 11 | $0 (2020) |
| Purdue Pharma L.P. | $148.89 | 12 | $0 (2017) |
| Amgen Inc. | $123.42 | 6 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $115.68 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.26 | 16 | ABBVIE INC. ($190.99) |
| 2023 | $734.97 | 44 | AbbVie Inc. ($333.20) |
| 2022 | $998.94 | 63 | ABBVIE INC. ($359.32) |
| 2021 | $540.44 | 35 | AbbVie Inc. ($146.25) |
| 2020 | $494.88 | 29 | PFIZER INC. ($219.71) |
| 2019 | $478.71 | 40 | PFIZER INC. ($184.03) |
| 2018 | $587.01 | 56 | PFIZER INC. ($292.62) |
| 2017 | $839.23 | 78 | PFIZER INC. ($234.42) |
All Payment Transactions
361 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: PAIN | ||||||
| 09/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | DePuy Synthes Sales Inc. | MONOVISC (Device), ORTHOVISC | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Sports Early Intervention | ||||||
| 08/20/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: PAIN | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: PAIN | ||||||
| 05/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: PAIN | ||||||
| 03/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Neurology | ||||||
| 01/24/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: PAIN | ||||||
| 01/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: PAIN | ||||||
| 11/13/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: PAIN | ||||||
| 10/30/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: PAIN | ||||||
| 10/11/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: PAIN | ||||||
| 09/11/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 408 | 666 | $130,804 | $49,739 |
| 2022 | 14 | 405 | 684 | $119,367 | $48,551 |
| 2021 | 12 | 352 | 641 | $101,900 | $42,954 |
| 2020 | 8 | 254 | 693 | $65,346 | $27,529 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 124 | 210 | $31,500 | $15,098 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 94 | $20,210 | $7,966 | 39.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 48 | 48 | $16,128 | $6,286 | 39.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 29 | 29 | $11,752 | $4,393 | 37.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 23 | 41 | $15,912 | $3,587 | 22.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 11 | 13 | $8,000 | $2,710 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,544 | $2,541 | 33.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 14 | 14 | $6,664 | $2,536 | 38.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 22 | 22 | $5,610 | $1,959 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 30 | $4,380 | $1,914 | 43.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 12 | 12 | $1,920 | $456.41 | 23.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 23 | 56 | $1,110 | $283.88 | 25.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 74 | $74.00 | $7.21 | 9.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 103 | 179 | $19,800 | $13,093 | 66.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 87 | $18,705 | $7,161 | 38.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 38 | 38 | $12,768 | $5,108 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 77 | $11,242 | $5,045 | 44.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 24 | 24 | $9,744 | $3,756 | 38.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 18 | 35 | $12,240 | $2,781 | 22.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 11 | 12 | $7,000 | $2,587 | 37.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 13 | 13 | $6,188 | $2,415 | 39.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 21 | 22 | $5,610 | $2,024 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $5,564 | $1,998 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,920 | $1,751 | 35.6% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 12 | 13 | $4,550 | $578.05 | 12.7% |
About Dr. Thomas Rossi, MD
Dr. Thomas Rossi, MD is a Sports Medicine healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821083528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Rossi, MD has received a total of $4,984 in payments from pharmaceutical and medical device companies, with $310.26 received in 2024. These payments were reported across 361 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,984).
As a Medicare-enrolled provider, Rossi has provided services to 1,419 Medicare beneficiaries, totaling 2,684 services with total Medicare billing of $168,773. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Dublin, OH
- Active Since 09/19/2005
- Last Updated 01/13/2016
- Taxonomy Code 2081S0010X
- Entity Type Individual
- NPI Number 1821083528
Products in Payments
- LYRICA (Drug) $784.54
- NURTEC ODT (Drug) $623.48
- QULIPTA (Drug) $620.44
- UBRELVY (Drug) $354.61
- GRALISE (Drug) $268.22
- Nucynta (Drug) $179.41
- Horizant (Drug) $177.72
- XTAMPZA (Drug) $166.96
- BOTOX (Biological) $130.71
- Aimovig (Biological) $123.42
- Dysport (Drug) $80.21
- HYSINGLA ER (Drug) $72.69
- LORZONE (Drug) $71.36
- NUEDEXTA (Drug) $67.09
- Gralise (Drug) $64.85
- BUTRANS (Drug) $64.41
- DYSPORT (Drug) $59.39
- AIMOVIG (Biological) $57.98
- REYVOW (Drug) $52.51
- RELISTOR (Drug) $51.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Dublin
Robert Magnussen, Md, MD
Sports Medicine — Payments: $12,426
Brian Skura
Sports Medicine — Payments: $8,021
Patricia Bornhorst, D.o, D.O
Sports Medicine — Payments: $517.86
Raymond Pongonis, D.o, D.O
Sports Medicine — Payments: $80.75
Dr. Victor Strimbu, M.d, M.D
Sports Medicine — Payments: $25.80
Dr. Thomas Hospel, Md, MD
Sports Medicine — Payments: $24.45